Insight

Justin Stebbing: A Complete Response in Cancer Using iNKT Cells

Justin Stebbing/healthpost.in

Jul 12, 2025, 16:57

Justin Stebbing: A Complete Response in Cancer Using iNKT Cells

Justin Stebbing, Editor-in-Chief of Oncogene and Professor of Biomedical Sciences at Anglia Ruskin University, shared a post on LinkedIn about a paper he co-authored with colleagues published in Oncogene:

“A remarkable case report I was lucky enough to be involved in, a complete response in late-line testicular cancer, using salvage therapy with iNKT cells, a new form of off-the-shelf cell therapy.”

Title: Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor

Authors: Benjamin Garmezy, Joseph E. Grossman, Jennifer Buell, Thiago Favano, Justin Stebbing, Steven O’Day, Marco A. Purbhoo, Dhan Chand, F. Anthony Greco

You can read the Full Article in Oncogene.

Justin Stebbing: A Complete Response in Cancer Using iNKT Cells

More posts featuring Justin Stebbing.

Benjamin Garmezy cancer Dhan Chand F. Anthony Greco iNKT cell therapy iNKT cells Jennifer Buell Joseph E. Grossman Justin Stebbing Marco A. Purbhoo OncoDaily oncogene Oncology Steven O'Day Thiago Favano

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers